PAVmed Inc.
NASDAQ:PAVM
0.7289 (USD) • At close April 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,995 | 2.452 | 0.377 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 4,840 | 6.42 | 3.614 | 0.585 | 0.023 | 0.014 | 0.01 | 0.007 | 0.004 | 0 | 0 |
| Gross Profit
| -1,845 | -3.968 | -3.237 | -0.085 | -0.023 | -0.014 | -0.01 | -0.007 | -0.004 | 0 | 0 |
| Gross Profit Ratio
| -0.616 | -1.618 | -8.586 | -0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5,932 | 14.276 | 25.547 | 19.847 | 10.963 | 6.63 | 4.253 | 2.619 | 1.72 | 0.489 | 0.022 |
| General & Administrative Expenses
| 24,524 | 30.947 | 41.041 | 25.566 | 12.388 | 7.665 | 6.31 | 5.415 | 3.931 | 1.287 | 0 |
| Selling & Marketing Expenses
| 11,627 | 17.583 | 19.318 | 8.895 | 2.789 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 36,151 | 48.53 | 60.359 | 34.461 | 12.388 | 7.665 | 6.31 | 5.415 | 3.931 | 1.287 | 0.4 |
| Other Expenses
| 559 | 2.021 | 1.784 | 0 | 0 | -0.559 | -0.903 | -3.124 | 0 | 0 | 0 |
| Operating Expenses
| 42,642 | 64.827 | 87.69 | 54.308 | 23.351 | 14.295 | 10.563 | 8.034 | 5.651 | 1.777 | 0.549 |
| Operating Income
| -44,487 | -68.795 | -90.927 | -54.393 | -23.351 | -14.295 | -10.563 | -8.034 | -5.651 | -1.777 | -0.422 |
| Operating Income Ratio
| -14.854 | -28.057 | -241.186 | -108.786 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 72,914 | -10.468 | -12.151 | -1.733 | -12.537 | -2.973 | -7.61 | -1.485 | 0 | 0 | -0.126 |
| Income Before Tax
| 28,427 | -79.263 | -103.238 | -56.126 | -35.888 | -17.268 | -18.173 | -9.519 | -5.651 | -1.777 | -0.549 |
| Income Before Tax Ratio
| 9.491 | -32.326 | -273.841 | -112.252 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -3,539 | 0 | -1.944 | -5.779 | -1.559 | -1.337 | -0.204 | 0.879 | -0 | -1.777 | -0.126 |
| Net Income
| 31,966 | -64.175 | -101.294 | -50.347 | -34.329 | -15.931 | -17.969 | -9.519 | -5.651 | -1.777 | -0.549 |
| Net Income Ratio
| 10.673 | -26.173 | -268.684 | -100.694 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 3.3 | -9.164 | -15.032 | -9.797 | -10.93 | -8.309 | -12.626 | -11.55 | -6.6 | -2.002 | -0.306 |
| EPS Diluted
| 3.3 | -9.164 | -15.032 | -9.797 | -10.93 | -8.309 | -12.626 | -11.55 | -6.6 | -2.002 | -0.306 |
| EBITDA
| -44,487 | -75.742 | -99.412 | -55.9 | -35.812 | -16.671 | -12.071 | -11.151 | -5.647 | -1.777 | -0.126 |
| EBITDA Ratio
| -14.854 | -30.89 | -263.692 | -111.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |